Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Merck & Co., Inc., dated Jan. 14, 2000.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.

Published Date:     Jan. 14, 2000

Company Name:       Merck & Co., Inc.

Address:            One Merck Drive
                    Whitehouse Station, NJ 08889

Main Telephone
 Number:            908/423-1000

Internet Home
 Page Address
  (URL)             www.merck.com

Chief Executive
 Officer:           Raymond V. Gilmartin

Chief Financial
 Officer:           Judy C. Lewent

Investor Relations
 Contact:           Laura Jordan
 Business number:   908/423-5185

Public Relations
 Contact:           Greg Reaves
 Business number:   908/423-6022

Industry:           Pharmaceutical

Trading Symbol/
 Exchange:          NYSE:MRK


Company Description: Merck Merck may refer to:
  • Merck & Co., Inc. ( MSD, Merck Sharp & Dohme outside of the United States and Canada), the USA pharmaceutical company created from assets forfeited after World War I by:
 & Co., Inc is a global, research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of human and animal health products, directly and through our joint ventures, and provides pharmaceutical benefit services through Merck-Medco Managed Care.

(all figures as of Dec. 1998)

Sales - $26.89 billion

R&D - $1.8 billion

Net income - $5.25 billion

Earnings per share - $2.15
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 14, 2000
Words:177
Previous Article:Corporate Profile for Marin Digital, dated Jan. 14, 2000.
Next Article:Corporate Profile for Scudder Kemper Investments, Inc., dated Jan. 14, 2000.
Topics:



Related Articles
Multex.com News -- Multex.com ACE Consensus Estimates, Merck & Co. Inc.
Merck to Withdraw From O-T-C Joint Venture in Japan.
Multex.com Stock Snapshot - Merck and Company Inc. MRK.
Axonyx Inc. Names A.E. Cohen, Former Senior Vice President of Merck, to Its Board of Directors.
Corporate Profile for Merck & Co., Inc., dated May 26, 2000.
Drug Spending To Double in Five Years; Half of Increase Fueled by Two Categories of Drugs.
Progressive Information Technologies' Target 2000 Chosen by Merck & Co., Inc. for the Publication of the 13th Edition of the Merck Index in Multiple...
Merck & Co., Inc. Plans to Establish Merck-Medco as a Separate, Publicly Traded Company.
BRIEFCASE.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles